Recruiting

SMR Stemless Reverse vs. SMR Reverse

Sponsor:

Limacorporate S.p.a

Code:

NCT04697004

Conditions

Arthroplasty, Replacement

Eligibility Criteria

Sex: All

Age: 22+

Healthy Volunteers: Not accepted

Interventions

Investigational Arm: SMR Stemless Reverse

Control Arm: SMR Reverse Shoulder System

Study Details

Brief summary:

The SMR Stemless Reverse is intended for total, primary shoulder joint replacement by reducing pain and restoring shoulder articular mobility function. This is a prospective, multi-center, randomized, controlled trial to demonstrate non-inferiority of the SMR Stemless Reverse to the SMR Reverse Shoulder System.

Patients with joint dysfunction who continue to experience significant symptoms despite an appropriate course of non-operative management are eligible. Patients will be considered enrolled into the study when an ICF has been signed, all inclusion criteria are met and no exclusion criteria are present including intraoperative exclusion criteria, and the patient is randomized into either the SMR Stemless Reverse (investigational) group, the SMR Reverse Shoulder System (control) group or is part of the roll-in population. Enrollment is expected to take approximately 24 months.

Conditions

Arthroplasty, Replacement

Study ID

NCT04697004

Start date

Apr 1, 2021

Status verified date

Oct, 2023

Completion date

Mar 30, 2026

Anticipated

Primary completion date

Mar 30, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 22+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Age ≥ 22 years of age
2. Skeletally mature as evident by scapula and proximal humerus closure
3. Candidate for primary total shoulder replacement in a grossly rotator cuff deficient joint with severe arthropathy (disabled shoulder), when clinical indications based on physical exam and medical history including one or more of the following:

1. Arthritis with rotator cuff tear not reparable
2. Irreparable rotator cuff tear
3. Rotator cuff tear arthropathy
4. Severe osteoarthritis and rotator cuff deficiency or stiff shoulder
5. Significant glenoid or socket side bone deformed or loss
6. Reoccurrence of instability or a chronic shoulder dislocation
7. Any other medical reason that the investigator determine that subject is a good candidate for a reverse total shoulder arthroplasty

Exclusion Criteria:

1. BMI > 40 kg/m2
2. Previous contralateral shoulder surgery within 3 months of enrollment or that requires active treatment (i.e. surgery or brace)
3. Had surgery in the targeted shoulder within last 12 months of enrollment, except diagnostic arthroscopy without procedures
4. Had surgery in lower limbs (such as hip or knee) within last 6 months of enrollment
5. Corticosteroid injections in the ipsilateral shoulder within 3 months of enrollment
6. Complete deltoid muscle insufficiency
7. Glenoid retroversion great than 25 degrees based off a 2D axial CT scan
8. History of/or signs and/or symptoms of local or systemic infection including but not limited to septicemia; osteomyelitis
9. Neurologically confirmed nerve lesion compromising shoulder joint function
10. Poor meta-epiphyseal bone stock compromising stability of the implant including but not limited to humeral head fracture, iatrogenic glenoid fracture, severe osteoporosis
11. Metabolic disorders which may impair fixation and stability of the implant including but not limited to uncontrolled diabetes mellitus with an HbA1C > 7.5%
12. Extended bone loss after previous surgery defined as: complete bone loss of greater and lesser tuberosity
13. Meta-epiphyseal bony defect (including large cyst)

Study Design

Enrollment

200 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: SMR Stemless Reverse

active comparator: SMR Reverse Shoulder System

Interventions

Investigational Arm: SMR Stemless Reverse

The SMR Stemless Reverse is intended for total, primary shoulder joint replacement by reducing pain and restoring shoulder articular mobility function.

Control Arm: SMR Reverse Shoulder System

Conventional stemmed shoulder prostheses are commonly used in the clinical practice.

Primary outcome measure

  • Primary Efficacy Endpoint-Constant Murley Score [ Time Frame: 24 Months ]
  • Primary Safety Endpoint-Absence of revisions, reoperations, and implant loosening. [ Time Frame: 24 Months ]

Central Contacts and Locations

Locations

Levy Shoulder Center

Recruiting

Boca Raton, Florida, United States, 33428

AdventHealth

Recruiting

Orlando, Florida, United States, 32803

Contacts

Rush Orthopaedics

Recruiting

Chicago, Illinois, United States, 60612

Contacts

Upstate Orthopedics

Recruiting

East Syracuse, New York, United States, 13057

Contacts

Rothman Orthopaedic

Recruiting

Philadelphia, Pennsylvania, United States, 19107

Contacts

Guthrie

Recruiting

Sayre, Pennsylvania, United States, 18840

Contacts

University of Texas- Health Science Center

Recruiting

San Antonio, Texas, United States, 78229

More Information

Sponsor

Limacorporate S.p.a

Last update posted

Oct 2, 2024

Last verified

Oct, 2023

Keywords

  • Shoulder Joint
  • Shoulder Replacement
  • Arthritis with rotator cuff tear
  • Post traumatic fracture sequele
  • Severe osteoarthritis and rotator cuff deficiency
  • Significant glenoid or socket side bone deformed or loss
  • Reoccurrence of instability or chronic shoulder dislocation
  • Severe osteoarthritis and stiff shoulder

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Limacorporate S.p.a on 2024-10-02.